Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
10/2003
10/30/2003WO2003089412A1 Antibacterial agents
10/30/2003WO2003043577A3 Modulators of rho c activity
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1357124A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/28/2003US6638955 Antibiotic oxazolidinone derivatives
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1204676B1 Streptogramin derivatives, preparation and compositions containing same
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635635 Benzothiadiazine compounds
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084960A1 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands
10/16/2003WO2003069397A3 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195213 A methylene-4-oxo-2-thionothiazolidin derivatives viricides for treating infections caused by Flavivirous
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/14/2003US6632919 Bind Watson-Crick base pairs in a double helix; specific for thymidine
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2002030357A9 Compounds and methods for modulating ccr4 function
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191165 Substance GM-95, process for producing the same and utilization thereof
10/09/2003US20030191138 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/08/2003EP1350794A1 Process for preparing substance gm-95
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/07/2003US6630470 G-CSF mimetics
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080585A1 Novel aminobenzamide derivative
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003US20030187258 Bactericides
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186973 2-Thia-1,6,8-Triaza-Naphthalene-2,2-Dioxides are kinase inhibitors
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186959 Central nervous system disorders
10/02/2003US20030186924 Prodrugs
10/02/2003CA2488161A1 Novel aminobenzamide derivative
10/01/2003EP1348710A1 Sulfonamide derivatives of 3-substituted imidazo[1,2-D]-1,2,4-thiadiazoles and 3-substituted-[1,2,4]thiadiazolo[4,5-A]benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
09/2003
09/30/2003US6627753 Agricultural insecticides
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/28/2003CA2379375A1 Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
09/25/2003WO2003078441A1 Aminomethyl-substituted thiazolobenzimidazole derivative
09/25/2003WO2003078434A1 Ethane-1,2-diamino-bis[(2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents
09/25/2003WO2003077847A2 Substituted amides
09/25/2003US20030181728 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
09/25/2003US20030181456 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting
09/25/2003US20030181437 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound
09/25/2003CA2479620A1 Ethane-1,2-diamino-bis[2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003CA2477732A1 Aminomethyl-substituted thiazolobenzimidazole derivatives
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1345947A1 A new process for preparing fused 1,2,4-thiadiazine derivatives
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/24/2003CN1444588A Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity
09/24/2003CN1122038C Heterocycle fused thiazole derivatives
09/23/2003US6624314 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624171 Useful as cyclin dependent kinase 11 inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar- palmar syndrome, mucositis) induced by chemotherapy and/or radiation therapy
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176474 Modulators of Rho C activity
09/18/2003US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 152